Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
St. Jude Medical’s largest investor boosts its stake by more than 30%, to some 27.2 million shares, or about 10% of the medical device maker.
The U.S. Securities & Exchange Commission subpoenas health products giant Baxter International for documents on the recall of its Colleague and Syndeo infusion pumps.
Accuray CEO Euan Thomson discusses the finer points of robotic prostate cancer treatment and the motivation behind a head-to-head clinical trial pitting its CyberKnife radiosurgery system against Intuitive Surgical’s da Vinci.